Gelsomino Marco, Tsouras Theo, Millar Ian, Fock Andrew
Hyperbaric Medicine Service, The Alfred Hospital, Melbourne, Victoria, Australia.
Kleinhűningerstrasse 177, 4057 Basel, Switzerland,
Diving Hyperb Med. 2017 Sep;47(3):191-197. doi: 10.28920/dhm47.3.191-197.
When a standard water-seal pleural drain unit (PDU) is used under hyperbaric conditions there are scenarios where excessive negative intrapleural pressure (IPP) and/or fluid reflux can be induced, risking significant morbidity. We developed and tested a pleural vacuum relief (PVR) device which automatically manages these risks, whilst allowing more rapid hyperbaric pressure change rates.
The custom-made PVR device consists of a one-way pressure relief valve connected in line with a sterile micro filter selected for its specific flow capacity. The PVR device is designed for connection to the patient side sampling port of a PDU system, allowing inflow of ambient air whenever negative pressure is present, creating a small, controlled air leak which prevents excessive negative pressure. The hyperbaric performance of a Pleur-Evac A-6000 intercostal drain was assessed with and without this added device by measuring simulated IPP with an electronic pressure monitor connected at the patient end of the PDU. IPP readings were taken at 10, 15, 20 and 30 cmH₂O of suction (set on the drain unit) at compression rates of 10, 30, 60, 80, 90 and 180 kPa·min⁻¹ to a pressure of 280 kPa.
At any compression rate of > 10 kPa·min⁻¹, the negative IPP generated by the Pleur-Evac A-6000 alone was excessive and resulted in back flow through the PDU water seal. By adding the PVR device, the generated negative IPP remains within a clinically acceptable range, allowing compression rates of at least 30 kPa·min⁻¹ with suction settings up to -20 cmH₂O during all phases of hyperbaric treatment.
The PDU PVR device we have developed works well, minimising attendant workload and automatically avoiding the excessive negative IPPs that can otherwise occur. This device should only be used with suction.
当在高压条件下使用标准水封胸腔引流装置(PDU)时,存在可能导致胸膜腔内负压(IPP)过大和/或液体反流的情况,从而有引发严重并发症的风险。我们研发并测试了一种胸膜腔真空缓解(PVR)装置,该装置可自动管理这些风险,同时允许更快的高压压力变化率。
定制的PVR装置由一个单向减压阀与一个因其特定流量而选择的无菌微滤器串联组成。PVR装置设计用于连接到PDU系统的患者侧采样端口,当存在负压时允许环境空气流入,形成一个小的、可控的空气泄漏,从而防止负压过大。通过在PDU患者端连接电子压力监测器测量模拟IPP,评估了添加该装置和未添加该装置时Pleur-Evac A-6000肋间引流装置的高压性能。在将引流装置设置为10、15、20和30 cmH₂O负压(设置在引流装置上)的情况下,以10、30、60、80、90和180 kPa·min⁻¹的压缩速率将压力压缩至280 kPa时读取IPP值。
在任何大于10 kPa·min⁻¹的压缩速率下,仅Pleur-Evac A-6000产生的负IPP过大,导致液体通过PDU水封回流。通过添加PVR装置,产生的负IPP保持在临床可接受范围内,在高压治疗的所有阶段,允许在负压设置高达-20 cmH₂O的情况下至少30 kPa·min⁻¹的压缩速率。
我们研发的PDU PVR装置运行良好,可最大限度地减少护理工作量,并自动避免可能出现的过大负IPP。该装置仅应在有负压的情况下使用。